Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The following protocols represent commonly reported approaches, though individual response varies and conservative starting doses remain prudent
However, its effectiveness can vary, and more research is needed to fully understand its long-term impacts
(3) Amount of Separate Payment for Diagnostic Radiopharmaceuticals Exceeding the Threshold As discussed in the CY 2025 OPPS/ASC final rule with comment period (89 FR 93955 through 93959), once we determine that the per day cost of a nonpass-through diagnostic radiopharmaceutical exceeds the cost threshold, proposed to be $655 per day for CY 2026, we will then assign that radiopharmaceutical to an APC, making it a specified covered outpatient drug (SCOD) per section 1833(t)(14)(B) of the Act
She was very informative and made me feel at ease with the entire process
This estimate is utilized for the accounting statement displayed in Table 170 of this final rule with comment period because the impact of this final CY 2026 policy, which is not budget neutral, is combined with the impact of the OPD update, which is also not budget neutral, to estimate changes in Medicare spending under the OPPS as a result of the changes in this rule
Return to all activities immediately perfect for busy schedules
